Drawing for QUIKSCREEN

USPTO serial 99767690

QUIKSCREEN

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SMITH, LAURA E
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with QUIKSCREEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Elizabeth Milesnick

Elizabeth Milesnick IdeaLegal2240 N Interstate Ave., Ste 230Portland, OR 97227United States

Goods and services

ClassDescriptionStatusFirst use
005Biological preparations for the treatment of HIV, Hepatitis B (HBV), Hepatitis C (HCV), Hepatitis A (HAV), Helicobacter pylori infection (H. pylori), Dengue, and Syphilis; Chemical preparations for pharmaceutical or medical purposes, namely, for pregnancy testing preparations, tumor testing preparations, infectious disease testing preparations, cardiovascular disease testing preparations, drug testing preparations and immune disease testing preparations; Chemical preparations for the diagnosis of pregnancy; Chemical reagents for medical or veterinary purposes; Cultures of microorganisms for medical or veterinary use; Diagnostic preparations for medical purposes; Pharmaceutical preparations for diagnosing infectious diseases, early stage pregnancy and tumorsACTIVEApr 16, 2025
010Blood testing apparatus; Cases fitted for medical instruments; Hematology analyzers for medical diagnostic uses; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical diagnostic apparatus for detecting substance abuse drug testing and testing for infectious diseases, cardiovascular disease, cerebrovascular disease, and fertility testing, all using a colloidal gold readout and photoelectric sensors; Medical diagnostic instruments for the analysis of body fluids; Medical instruments for analysing and identifying bacteriaACTIVEApr 16, 2025

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 2, 2026EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Nov 2, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 2, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 2, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 2, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 2, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 22, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 22, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 16, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 27, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 24, 2026DOCKASSIGNED TO EXAMINER—
Aug 23, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 16, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 16, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance